Company Name: |
Yichang Zhongyitai Trading Co., Ltd.
|
Tel: |
0717-6449896 13886658719 |
Email: |
root@zhongyitai.com |
Products Intro: |
Product Name:C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) CAS:151057-28-2 Purity:98+% Package:1mg
|
Company Name: |
Alfa Chemistry
|
Tel: |
1-516-6625404 |
Email: |
support@alfa-chemistry.com |
Products Intro: |
Product Name:C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) CAS:151057-28-2 Purity:98%+ Package:1g;10g;100g;1KG;5KG
|
Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
Tel: |
400-9205774 |
Email: |
sales@glpbio.cn |
Products Intro: |
Product Name:C24:1 3’-sulfo Galactosylceramide (d18:1/24:1(15Z)) CAS:151057-28-2 Purity:>98% Package:1mg;10mg;50mg;100mg;
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) CAS:151057-28-2 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) Basic information |
Product Name: | C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) | Synonyms: | C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z));C24:1 3’-sulfo Galactosylceramide (d18:1/24:1(15Z));15-Tetracosenamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-, (15Z)-;N-Tetracosenoyl-(cis-15)-sulfatide;N-[(1S)-2R-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3E-heptadecen-1-yl]-15Z-tetracosenamide;C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) | CAS: | 151057-28-2 | MF: | C48H91NO11S | MW: | 890.3 | EINECS: | | Product Categories: | | Mol File: | 151057-28-2.mol | ![C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) Structure](CAS/20181012/GIF/151057-28-2.gif) |
| C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) Chemical Properties |
storage temp. | Store at -20°C | solubility | Chloroform:Methanol (5:1): soluble | form | A solid |
| C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) Usage And Synthesis |
Description | C24:1 3’-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. It is the predominate sulfatide species in mature myelin, and it accumulates at a higher rate than C24 3’-sulfo galactosylceramide in rat cerebellum from seven to 32 days of age when active myelination occurs.1 It interacts with C-type lectins and immunoglobulin-like receptors with the highest affinity for LMIR5.2 It induces production of MCP-1 in basophils but not mast cells and increases the activation of NFAT in a reporter assay via LMIR5. C24:1 3’-sulfo Galactosylceramide is an immunodominant species in myelin, is bound by CD1d in vitro, and increases proliferation in isolated mouse splenocytes.3 It reduces symptoms and increases survival in a mouse model of chronic relapsing-remitting experimental autoimmune encephalomyelitis (EAE) when used at a dose of 20 μg.4 It also decreases the number of inflammatory lesions and infiltrating mononuclear cells in the lumbar spinal cord of EAE mice. As this product is derived from a natural source, there may be variations in the sphingoid backbone. | Definition | ChEBI: 1-(3-O-sulfo-beta-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]sphingosine is an N-acyl-beta-D-galactosylsphingosine having a sulfo group at the 3-position on the galactose ring and (15Z)-tetracos-15-enoyl as the N-acyl group. It has a role as an epitope. It is a galactosylceramide sulfate and a N-acyl-beta-D-galactosylsphingosine. It is a conjugate acid of a 1-(3-O-sulfo-beta-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]sphingosine(1-). | References | 1. Marbois, B.N., Faull, K.F., Fluharty, A.L., et al. Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry Biochim. Biophys. Acta 1484(1),59-70(2000). 2. Phongsisay, V., Iizasa, E., Hara, H., et al. 3-O-sulfo-β-D-galactose moiety of endogenous sulfoglycolipids is a potential ligand for immunoglobulin-like receptor LMIR5 Mol. Immunol. 63(2),595-599(2015). 3. Zajonc, D.M., Maricic, I., Wu, D., et al. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity J. Exp. Med. 202(11),1517-1526(2005). 4. Maricic, I., Halder, R., Bischof, F., et al. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis J. Immunol. 193(3),1035-1046(2014). |
| C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) Preparation Products And Raw materials |
|